Anoro Ellipta 55 mcg/22 mcg
Anoro Ellipta 55 mcg/22 mcg is a medicine authorised by Swissmedic under authorisation number 63152. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 July 2014 and the authorisation is valid without a time limit. ATC code R03AL03 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 63152 |
|---|---|
| Name | Anoro Ellipta 55 mcg/22 mcg |
| Full name | Anoro Ellipta 55 mcg/22 mcg, Einzeldosiertes Pulver zur Inhalation |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03AL03 |
| First authorisation | 14 July 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Anoro Ellipta 55 mcg/22 mcg, Einzeldosiertes Pulver zur Inhalation | B | 14 July 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Einzeldose(n) | R03AL03 | 03.04.3. | B |
| 2 | 3 x 30 | Einzeldose(n) | R03AL03 | 03.04.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Anoro Ellipta 55 mcg/22 mcg authorised in Switzerland?
Yes. Anoro Ellipta 55 mcg/22 mcg is authorised by Swissmedic under authorisation number 63152, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Anoro Ellipta 55 mcg/22 mcg have?
Anoro Ellipta 55 mcg/22 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Anoro Ellipta 55 mcg/22 mcg?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.